Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  Theranexus    ALTHX   FR0013286259

THERANEXUS

(ALTHX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
All news about THERANEXUS
11/20THERANEXUS : - The Food And Drug Administration issues a favorable opinion on th..
AQ
11/20THERANEXUS : The Food And Drug Administration (FDA) issues a favorable opinion o..
PU
11/19THERANEXUS : The food and drug administration (fda) issues a favorable opinion o..
AN
11/05THERANEXUS : - Presentation of the results of the phase 1b clinical study with T..
AQ
11/04THERANEXUS : Presentation of the results of the phase 1b clinical study of THN20..
PU
11/04THERANEXUS : Presentation of the results of the phase ib clinical study of thn20..
AN
10/22THERANEXUS : TTHERANEXUS and the BBDF Foundation Obtain Orphan Drug Status in Eu..
AQ
10/21THERANEXUS : and BBDF obtain European "orphan medicinal product" designation for..
PU
10/16THERANEXUS : publishes its cash position as of September 30, 2020
AQ
09/30THERANEXUS : announces its first half results
AQ
09/10THERANEXUS : takes stock of its scientific news
AQ
09/09THERANEXUS : Theranexus presents its latest scientific news
AN
08/12THERANEXUS : and BBDF Foundation Achieve Orphan Drug and Rare Pediatric Disease ..
AQ
08/11THERANEXUS : Theranexus and bbdf obtain orphan drug designation (odd) and rare p..
AN
07/30THERANEXUS : Theranexus to present the results of thn102 for parkinson’s disease..
AN
07/21THERANEXUS : HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT 1st HALF 2020
AQ
07/10THERANEXUS : Announces its cash position at june 30, 2020 and the establishment ..
AQ
07/09THERANEXUS : Theranexus announces its cash position as of 30 june 2020 and imple..
AN
06/25THERANEXUS : obtains non-dilutive financing of EUR 3.4m in the form of a loan gu..
AQ
06/24THERANEXUS : Theranexus secures eur 3.4 m loan under the french state guarantee ..
AN
04/10THERANEXUS : - 2019 annual results and update on the progress of activities
AQ
04/09THERANEXUS : 2019 full-year results and update on activities
AN
04/01THERANEXUS : Announces Successful Phase 2 Study for THN102 in Parkinson's diseas..
AQ
03/31THERANEXUS : Theranexus announces the success of its phase ii trial for thn102 i..
AN
01/28THERANEXUS : publishes its cash position as of December 31, 2019
AQ
01/27THERANEXUS : Theranexus reports cash position as of december 31, 2019
AN
01/21THERANEXUS : Publie son agenda financier 2020
AQ
01/20THERANEXUS : Theranexus announces its financial calendar for 2020
AN
01/16THERANEXUS : Announces the clinical results of its phase ib study demonstrating ..
AQ
01/15THERANEXUS : Theranexus announces the clinical results of its phase ib study dem..
AN
2019THERANEXUS : Theranexus and Beyond Batten Disease Foundation (BBDF) announce the..
AN
2019THERANEXUS : Theranexus reports cash position as of september 30, 2019
AN
2019THERANEXUS : Theranexus announces its first half 2019 results
AN
2019THERANEXUS : A new milestone reached for theranexus: inclusion of last patient i..
AN
2019THERANEXUS : Theranexus announces inclusion of last subject in its phase ib tria..
AN
2019THERANEXUS : Theranexus announces the publication of two scientific papers and a..
AN
2019THERANEXUS : Theranexus raises approximately 2.2 million euros in a placement re..
AN
2019THERANEXUS : Theranexus announces the launch of a capital increase by private pl..
AN
2019THERANEXUS : Theranexus reports cash position as of june 30, 2019
AN
2019THERANEXUS : Theranexus and Beyond Batten Disease Foundation (BBDF) announce agr..
AN
2019THERANEXUS : THERANEXUS INVITED TO JOIN IN THE HEALTHTECH INVESTOR DAYS (HTID) 2..
AN
2019THERANEXUS : Theranexus announces the formation of its scientific board
AN
2019THERANEXUS : Theranexus to present new data on neuron-glia interactions at two s..
AN
2019THERANEXUS : Theranexus announces issuance of chinese patent covering its drug c..
AN
2019THERANEXUS : Theranexus provides 2018 full-year results and update on activities
AN
2019THERANEXUS : Theranexus announces research collaboration with irisa* using artif..
AN
2019THERANEXUS : Theranexus to present new scientific data on drug candidate thn201 ..
AN
2019THERANEXUS : Theranexus announces preliminary results of phase ii trial of thn10..
AN
2019THERANEXUS : Theranexus reports cash position as of 31 december 2018 and provide..
AN
2019THERANEXUS : THERANEXUS set to receive EUR 6.2 million in funding from the Frenc..
AN
2019THERANEXUS : Theranexus announces its financial calendar for 2019
AN
2018THERANEXUS : Theranexus announces appointment of jerome martinez to its board of..
AN
2018THERANEXUS : Theranexus september 30th cash position and business update
AN
2018THERANEXUS : Theranexus announces inclusion of last patient in phase ii trial of..
AN
2018THERANEXUS : Theranexus plans to expand its phase ii pipeline with a third progr..
AN
2018THERANEXUS : Theranexus announces that rodolphe besserve will join its board of ..
AN
2018THERANEXUS : Theranexus announces a new european patent protecting thn201, its d..
AN
2018THERANEXUS : Recognition of the scientific excellence of theranexus
AN
2018THERANEXUS : THERANEXUS ANNOUNCES ITS FIRST HALF 2018 RESULTS - CASH POSITION AT..
AN
2018THERANEXUS : THERANEXUS OBTAINS THE AUTHORIZATION TO START A PHASE Ib CLINICAL T..
AN
2018THERANEXUS : Theranexus announces the inclusion of the first patient in its phas..
AN
2018THERANEXUS : Theranexus presents new date on the stimulating effect of its drug ..
AN
2018THERANEXUS : Theranexus announces german authorities approval for its phase 2 cl..
AN
2018THERANEXUS : Theranexus announces the publication of a scientific article on the..
AN
2018THERANEXUS : Theranexus publishes its cash position as at 31 march 2018
AN
2018THERANEXUS : Theranexus presentation at the International Connexins Symposium (V..
AN
2018THERANEXUS : Oral presentation of theranexus at the 9th european congress on nar..
AN
2018THERANEXUS : Theranexus announces its 2017 annual results and presents an update..
AN
2018THERANEXUS : Thn102 obtains investigational new drug status from the food and dr..
AN
2018THERANEXUS : Theranexus announces the first european approval for its phase 2 cl..
AN
2018THERANEXUS : Theranexus announces a successful clinical pharmacokinetic study as..
AN
2018THERANEXUS : Theranexus and the college de france sign a research agreement on a..
AN
2018THERANEXUS : Theranexus announces issuance of european patent covering its drug ..
AN